Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.730
+0.580 (50.45%)
At close: Oct 9, 2026, 4:00 PM EDT
1.760
+0.030 (1.73%)
After-hours: Oct 9, 2026, 7:27 PM EDT

ZYBT Revenue

In the year 2025, Zhengye Biotechnology Holding had annual revenue of 116.36M CNY, down -37.56%. Zhengye Biotechnology Holding had revenue of 54.03M in the half year ending December 31, 2025, a decrease of -43.00%. That makes Zhengye Biotechnology Holding the 34,813th largest company in the world by revenue and 4,592nd in the United States.

Revenue (ttm)
116.36M CNY
Revenue Growth
-37.56%
P/S Ratio
6.84
Revenue / Employee
432,572 CNY
Employees
269
Market Cap
81.51M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025116.36M-69.99M-37.56%
Dec 31, 2024186.36M-25.30M-11.95%
Dec 31, 2023211.65M-48.62M-18.68%
Dec 31, 2022260.27M46.20M21.58%
Dec 31, 2021214.07M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.